[go: up one dir, main page]

AU2001234782A1 - Compositions and methods for promoting healthy joints - Google Patents

Compositions and methods for promoting healthy joints

Info

Publication number
AU2001234782A1
AU2001234782A1 AU2001234782A AU3478201A AU2001234782A1 AU 2001234782 A1 AU2001234782 A1 AU 2001234782A1 AU 2001234782 A AU2001234782 A AU 2001234782A AU 3478201 A AU3478201 A AU 3478201A AU 2001234782 A1 AU2001234782 A1 AU 2001234782A1
Authority
AU
Australia
Prior art keywords
compositions
methods
promoting healthy
healthy joints
joints
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001234782A
Inventor
Jeffrey S. Bland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metagenics LLC
Original Assignee
Metagenics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metagenics LLC filed Critical Metagenics LLC
Publication of AU2001234782A1 publication Critical patent/AU2001234782A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001234782A 2000-02-02 2001-02-02 Compositions and methods for promoting healthy joints Abandoned AU2001234782A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17988500P 2000-02-02 2000-02-02
US60179885 2000-02-02
PCT/US2001/003497 WO2001056572A1 (en) 2000-02-02 2001-02-02 Compositions and methods for promoting healthy joints

Publications (1)

Publication Number Publication Date
AU2001234782A1 true AU2001234782A1 (en) 2001-08-14

Family

ID=22658388

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001234782A Abandoned AU2001234782A1 (en) 2000-02-02 2001-02-02 Compositions and methods for promoting healthy joints

Country Status (3)

Country Link
US (1) US20020025310A1 (en)
AU (1) AU2001234782A1 (en)
WO (1) WO2001056572A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10045059A1 (en) * 2000-09-12 2002-03-21 Basf Ag Therapeutic combination of lipoic acid and conjugate acids for the treatment of diabetic disorders
US7696219B2 (en) * 2000-09-27 2010-04-13 Everett Laboratories, Inc. Method and composition for supplementation of nutritional deficiences in renal patients
US6995166B1 (en) 2000-09-27 2006-02-07 Everett Laboratories, Inc. Method and composition for supplementation of nutritional deficiencies in renal patients
US6426424B1 (en) * 2000-10-11 2002-07-30 Albion International, Inc. Composition and method for preparing granular amino acid chelates and complexes
US6660293B2 (en) 2001-06-29 2003-12-09 Everett Laboratories, Inc. Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects
US7560123B2 (en) 2004-08-12 2009-07-14 Everett Laboratories, Inc. Compositions and methods for nutrition supplementation
US20030158171A1 (en) * 2001-11-28 2003-08-21 Albion International, Inc. Chelates and complexes for reduction in alcohol dependency
US8617617B2 (en) * 2002-12-10 2013-12-31 Everett Laboratories, Inc. Methods and kits for co-administration of nutritional supplements
US6814983B2 (en) * 2002-12-10 2004-11-09 Everett Laboratories, Inc. Compositions and methods for nutrition supplementation
US8101587B2 (en) * 2004-08-12 2012-01-24 Everett Laboratories, Inc. Kits for nutrition supplementation
JP4903796B2 (en) 2005-08-17 2012-03-28 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド Methods and compositions for prevention and treatment of kidney disease
US8148356B2 (en) * 2005-08-24 2012-04-03 Cumberland Pharmaceuticals, Inc. Acetylcysteine composition and uses therefor
CN102271676B (en) 2008-12-30 2014-07-23 希尔氏宠物营养品公司 Use of Lipoic Acid in the Treatment or Prevention of Degenerative Joint Disorders, Osteoarthritis, Cartilage Damage, and Related Disorders in Companion Animals
ITMI20090779A1 (en) * 2009-05-08 2010-11-08 Vitrupharm Srl NUTRITIONAL COMPOSITIONS BASED ON CISTEIN RESVERATROL OR ITS DERIVATIVES OR METABOLITES AND ASTAXANTIN
CN102138961A (en) * 2010-02-02 2011-08-03 北京绿色金可生物技术股份有限公司 Application of black bean peel extract in products for preventing and treating osteoarthritis
US20110217393A1 (en) * 2010-02-23 2011-09-08 Grise Michel Anti-fatigue composition
WO2012015969A1 (en) * 2010-07-27 2012-02-02 Imagenetix, Inc. Compositions and methods for increased delivery of coenzyme q10
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993013660A1 (en) * 1992-01-06 1993-07-22 Health Maintenance Programs, Inc. Pharmaceutically active antioxydant containing composition and the method of its use to prevent and treat restenosis following angioplasty
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
US5846569A (en) * 1997-06-20 1998-12-08 Creative Labs, Inc. Colostrum supplement
EP0891719A1 (en) * 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine

Also Published As

Publication number Publication date
US20020025310A1 (en) 2002-02-28
WO2001056572A1 (en) 2001-08-09

Similar Documents

Publication Publication Date Title
AU2002357119A1 (en) Mitocidal compositions and methods
AU2001251136A1 (en) Compositions and methods for promoting wound healing
AUPQ419099A0 (en) Novel compositions and methods
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2001234782A1 (en) Compositions and methods for promoting healthy joints
AU5565099A (en) Pharmaceutical compositions and methods for use
AU2001245987A1 (en) Compositions and methods for gene therapy
AUPP968699A0 (en) Therapeutic compositions and method for their preparation
AU2001292864A1 (en) Methods and compositions for modulating angiogenesis
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU3020899A (en) Compositions and methods for protein secretion
AU2001253137A1 (en) Composition and method for promoting oral health
AU2001233932A1 (en) Method and composition
AU3923000A (en) Agp-1 fusion protein compositions and methods
AU2001233086A1 (en) Ceramidase compositions and methods based thereon
AU2001275667A1 (en) Homocinetic joint
AU2002239775A1 (en) Chemical-library composition and method
AU2880699A (en) Pharmaceutical compositions and methods for use
AU2001259564A1 (en) Pharmaceutical compositions and methods for use
AU2001253469A1 (en) Compositions and methods for stabilizing modified tissue
AU5931300A (en) Ringene compositions and methods for use thereof
AU2002359869A1 (en) Pak5-related compositions and methods
AU2001261738A1 (en) Compositions and methods for promoting immunosuppression
AU2002321681A1 (en) Compositions and methods for the repair and construction of bone and other tissue
AU2002220638A1 (en) Joint prosthesis